U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06895187) titled 'Catheter Ablation Using a Novel Navigation and Imaging System' on March 24.
Brief Summary: The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).
Study Start Date: Sept. 01, 2025
Study Type: OBSERVATIONAL
Condition:
Paroxysmal Atrial Fibrillation
Intervention:
DEVICE: VERAFEYE System
VERAFEYE system guidance will be used on all patients undergoing PAF ablation.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: LUMA Vision Ltd.
Published by HT Digit...